Institutional
November 12 2025
2025-11-20
News
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (24)
- Nov (34)
- Dec (20)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Featured news
Latest news
Institutional
November 24 2025
2025-11-24
The Women Biology and Health Workshop successfully promotes health research with a gender perspective
Research
November 20 2025
2025-11-20
IDIBAPS-Hospital Clínic Barcelona receives two grants from the Fundació ”la Caixa” Health Research call
The project led by Pere Santamaria will study nanodrugs to combat autoimmune diseases such as type 1 diabetes. The proj1
Institutional
November 20 2025
2025-11-24
Clínic professionals receive Talents Grants from the Fundació Catalunya La Pedrera
The Talents Programme is a collaboration between the Fundació Catalunya La Pedrera and Germans Trias i Pujol University Hospital, the Vall d'Hebron I1
Health Topics
November 19 2025
2025-11-17
Improving diets could prevent 15 million deaths per year
Food choices impact both personal health and the health of the planet. The EAT–Lancet Commission presents an unprecedented global plan for more susta1
Research
November 18 2025
2025-11-18
IDIBAPS researchers boost computational neuroscience in northeastern Nigeria
This summer, a team of IDIBAPS researchers travelled Damaturu, Nigeria, to lead the first edition of an intensive cours1
Research
November 17 2025
2025-11-17
IDIBAPS welcomes researcher Thomas Walle to lead the new ‘Computational cancer biomedicine’ research group
The creation of the group was made possible thanks to the AECC grant received last year from the AECC-IDIBAPS Excellence Programme: Immunotherapy aga1